Merck's Shareholder TCW Cuts Stake After Cancer Vaccine Trial Success
TCW Group Inc., a financial institution, has adjusted its stake in Merck & Co., Inc. (NYSE:MRK) by selling 16,921 shares during the second quarter.
This move reduced TCW's position in MRK by 2%, with the fund now holding 845,538 shares of the company's stock.
The value of these holdings is approximately $108,652,000 at the end of the most recent reporting period.